Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan

Masayuki Iki(Kansai Medical University), Sumito Ogawa(University of Tokyo Hospital), Shinichi Nakatoh(Asahi General Hospital), Kenji Fujimori(Tohoku University), Nobukazu Okimoto(Kindai University), Hironori Imano(Kindai University), Junko Tamaki(Osaka University of Pharmaceutical Sciences), Shigeyuki Ishii(Tokyo University of Pharmacy and Life Sciences)
Osteoporosis International
January 24, 2024
Cited by 15


Related Papers